Showing 4,961 - 4,980 results of 25,035 for search '(( 50 ((ms decrease) OR (mean decrease)) ) OR ( 100 ((a decrease) OR (we decrease)) ))', query time: 0.95s Refine Results
  1. 4961

    An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

    Published 2025
    “…The initial experiments on pure gold films revealed a progressive retraction of gold clusters starting just above 100 °C, driven by thermally activated solid-state dewetting. …”
  2. 4962
  3. 4963

    LF4A-GFP localizes to the basal bodies and along cilia, is transported by IFT and affects IFT. by Yu-Yang Jiang (7036916)

    Published 2019
    “…<p>(A-B) A wild-type (negative control non-GFP expressing) cell (A) and a cell expressing LF4A-GFP under the native promoter (B) were subjected to simultaneous fixation/permeabilization (using a mixture of paraformaldehyde and Triton X-100) and stained with the anti-GFP antibodies (red) and DAPI (blue). …”
  4. 4964
  5. 4965

    Thermoresponsive On-Demand Adhesion and Detachment of a Polyurethane–Urea Bioadhesive by Hui Zhang (7197)

    Published 2024
    “…Furthermore, the present PUU-based adhesive also shows good on-demand underwater adhesion and detachment with a cell viability close to 100%. We propose that biomaterial research fields, especially novel PUU/polyurethane (PU)-based functional materials and bioadhesives, could benefit from such a novel thermoresponsive copolymer with outstanding mechanical and functional performances and an easy synthesis and scaled-up process as described in this article.…”
  6. 4966

    Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy by Yong-Chul Kim (1637572)

    Published 2013
    “…</p><p>Results</p><p>The mean value of pcUACR at 12-week and 16-week visits (primary outcome) was decreased more in the Tac group compared to the control group (–52.0±26.4 vs –17.3±29.3%, p = 0.001). …”
  7. 4967
  8. 4968
  9. 4969
  10. 4970
  11. 4971
  12. 4972
  13. 4973

    Pharmacodynamic Profile of CCX168 in Healthy Human Volunteers. by Pirow Bekker (392139)

    Published 2016
    “…(A) C5a-induced upregulation of CD11b on the surface of neutrophils in whole blood collected in the placebo group (●), and at 2 hours (♦) and 24 hours (◊) after a single dose of 10 mg CCX168, at 2 hours (▲) and 12 hours (Δ) after a single dose of 30 mg CCX168, and 2 hours (■) and 12 hours (□) after a single dose of 100 mg CCX168. …”
  14. 4974
  15. 4975
  16. 4976
  17. 4977

    Combination treatments increased p53 and decreased c-Myc levels in U-87MG and U-251MG cells more than did single treatments. by Panchanan Maiti (1459852)

    Published 2019
    “…<p>A-C: Western blot data showed that SLCP+BBR increased p53 and decreased c-Myc levels significantly more in U-87MG and U-251MG cells, in comparison to single treatments. …”
  18. 4978
  19. 4979
  20. 4980